Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range

Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% and closed at $0.0959 in last trading session. The biotech firm is still in clinical stage and it is working to develop targeted therapies to treat diabetes and cancer based on Cell-in-a-Box® technology. Recently, the COO of Pharmacyte, Dr. Gerald W. Crabtree, Ph.D. highlighted company’s development plans in an […]

In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

Boston, MA 11/27/2014 (wallstreetpr) – Avanir Pharmaceuticals Inc (NASDAQ:AVNR) suffered a blow this week when the U.S. Food and Drug Administration declined to approve its migraine drug device. The company had sought marketing approval for the device, which in many ways has good revenue promise. However, even though the FDA rejected the device, analysts believe that […]

AbbVie Inc. (NYSE:ABBV) May Withdraw Back From the Acquisition Of Shire Plc. (ADR) (NASDAQ:SHPG)

Boston, MA 10/16/2014 (wallstreetpr) – The drug maker Shire Plc. (ADR) (NASDAQ:SHPG) has lost about one-third of its market share in a trading at New York Exchange on Wednesday. The reason of the fall was news that AbbVie Inc. (NYSE:ABBV) who was about to acquire Shire may step back from this deal of acquisition worth […]

Is AbbVie Inc (NYSE:ABBV) Move To Merge With Shire PLC (ADR) (NASDAQ:SHPG) Falling apart?

Boston, MA 10/15/2014 (wallstreetpr) – AbbVie Inc (NYSE:ABBV) move to merge with the Britain-based Shire PLC (ADR) (NASDAQ:SHPG) is showing signs of falling apart. The principal reason for forming such an opinion is undoubtedly the latest tax inversion that was cracked down by the establishment. While AbbVie is dithering and considering the option of scrapping […]

AbbVie Inc. (NYSE:ABBV) $1.6 Billion Shire PLC (ADR) (NASDAQ:SHPG) Break-Up Fee Dilemma

Boston, MA 10/15/2014 (wallstreetpr) –  Proposals intended to make it difficult for American companies to shift their bases out of the U.S have reportedly forced AbbVie Inc. (NYSE:ABBV) to rethink its $55 billion takeover of Shire PLC (ADR) (NASDAQ:SHPG). AbbVie just like other companies is seeking to shift its base to Europe where tax rates are […]

AbbVie Inc (NYSE:ABBV) Faces Pension Fund Wrath On Its Merger Deal With Shire PLC (ADR) (NASDAQ:SHPG)

Boston, MA 09/18/2014 (wallstreetpr) – Research-based pharmaceutical company, AbbVie Inc (NYSE:ABBV) is facing the wrath of a pension fund in the U.S. since its merger with Shire PLC (ADR) (NASDAQ:SHPG) sought to shift its residential base to the United Kingdom. The Louisiana pension fund dragged the U.S. company to the court and charged them of […]

Medtronic, Inc. (NYSE:MDT) To Reimburse Top Executives, Directors For Inversion Taxes Bills

Boston, MA 09/02/2014 (wallstreetpr) – Medtronic, Inc. (NYSE:MDT) will compensate its top executives and directors for the tax imposed on their stock and option awards in relation to the inversion efforts that the company is undertaking, Wall Street Journal stated in an article. The company seeks to shift its corporate office from the U.S. through […]

Shire PLC (ADR) (NASDAQ:SHPG) Rejects $47 Billion Takeover Offer, But More To Come

Boston, MA 06/23/2014 (wallstreetpr) – Shire PLC (ADR) (NASDAQ:SHPG), a $44 billion specialty biopharmaceutical company based in Ireland, rejected at least three takeover offers from AbbVie Inc (NYSE:ABBV). The company declined $46.5 billion purchase offer as its board of directors said the proposal undervalues the company’s prospects. Furthermore, the board said the proposal was “highly conditional.” […]

Allergan, Inc. (NYSE:AGN) To Offer New Takeover Bid ToShire PLC (ADR) (NASDAQ:SHPG)

Dallas, Texas 04/29/2014 (ustradevoice) – After being refused earlier for takeover negotiations, Allergan, Inc. (NYSE:AGN) decides to go forward for a more serious takeover talks with Shire PLC (ADR) (NASDAQ:SHPG), as per the Reuter’s report. Allergan, renowned as a Botox maker, is strongly in a lookout to acquire Shire in order to prevent itself from a […]